2025-04-04 19:35:46
Latest Post
Sai Life Sciences sets up Peptide Research Center in India
Netweb Technologies Ltd receives PLI Incentive Under IT Hardware Scheme 2.0
BHEL signs contract for ± 800 kV, 6000 MW Bhadla-Fatehpur LCC HVDC Terminal Station along with AC Transmission at Bhadla and Fatehpur
DEE Development Engineers Limited receives order worth approx. Rs. 55 crores- SURATWWALA BUSINESS GROUP Ltd purchases new commercial office space
Stock Report
Astec LifeSciences Ltd reports consolidated loss of Rs. 4.98 crores in Q4FY23
Posted On : 2023-05-02 23:35:43( TIMEZONE : IST )
Astec LifeSciences Limited has reported Consolidated financial results for the period ended March 31, 2023.
Financial Results (Q4 FY2023) - QoQ Comparison
The company has reported total income of Rs. 129.5469 crores during the period ended March 31, 2023 as compared to Rs. 120.9697 crores during the period ended December 31, 2022.
The company has posted net profit / (loss) of Rs. -4.9833 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 0.8397 crores for the period ended December 31, 2022.
The company has reported EPS of Rs. -2.54 for the period ended March 31, 2023 as compared to Rs. 0.43 for the period ended December 31, 2022.
| Financials | Q4 FY2023 | Q3 FY2023 | % Change |
| Total Income | ₹129.5469 crs | ₹120.9697 crs |  7.09% |
| Net Profit | ₹-4.9833 crs | ₹0.8397 crs |  -693.46% |
| EPS | ₹-2.54 | ₹0.43 | -690.70% |
Financial Results (Q4 FY2023) - YoY Comparison
The company has reported total income of Rs.129.5469 crores during the period ended March 31, 2023 as compared to Rs.278.7868 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs.-4.9833 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.43.0546 crores for the period ended March 31, 2022.
The company has reported EPS of Rs.-2.54 for the period ended March 31, 2023 as compared to Rs.21.96 for the period ended March 31, 2022.
| Financials | Q4 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹129.5469 crs | ₹278.7868 crs | -53.53% |
| Net Profit | ₹-4.9833 crs | ₹43.0546 crs | -111.57% |
| EPS | ₹-2.54 | ₹21.96 | -111.57% |
Financial Results (Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.641.2263 crores during the Financial Year ended March 31, 2023 as compared to Rs.687.0339 crores during the Financial Year ended March 31, 2022.
The company has posted net profit / (loss) of Rs.25.5649 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.89.8586 crores for the Financial Year ended March 31, 2022.
The company has reported EPS of Rs.13.04 for the Financial Year ended March 31, 2023 as compared to Rs.45.85 for the Financial Year ended March 31, 2022.
| Financials | Year Ended FY2023 | Year Ended FY2022 | % Change |
| Total Income | ₹641.2263 crs | ₹687.0339 crs | -6.67% |
| Net Profit | ₹25.5649 crs | ₹89.8586 crs | -71.55% |
| EPS | ₹13.04 | ₹45.85 | -71.56% |
Shares of Astec LifeSciences Limited was last trading in BSE at Rs. 1350.75 as compared to the previous close of Rs. 1329.95. The total number of shares traded during the day was 727 in over 167 trades.
The stock hit an intraday high of Rs. 1360.75 and intraday low of 1329.40. The net turnover during the day was Rs. 981197.00.
